Da: Preferred Books, Rancho Cucamonga, CA, U.S.A.
Prima edizione
Hardcover. Condizione: Fine. 1st Edition. Fine condition. Looks unread.
Da: killarneybooks, Inagh, CLARE, Irlanda
Prima edizione
EUR 19,50
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Good+. 1st Edition. Hardcover, x + 294 pages, NOT ex-library. Interior is very good: clean and bright throughout, with unmarked text, free of inscriptions and stamps, firmly bound. Gently shelfworn boards show two tiny closed edge-nicks (upper corner of the front panel), creases to the lower spine. Issued without a dust jacket.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: BennettBooksLtd, Los Angeles, CA, U.S.A.
Hardcover. Condizione: New. In shrink wrap. Looks like an interesting title!
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: Ubiquity Trade, Miami, FL, U.S.A.
EUR 157,77
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Brand new! Please provide a physical shipping address.
Condizione: New. pp. x + 294 Index 1st Edition.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Prima edizione
EUR 154,91
Quantità: 15 disponibili
Aggiungi al carrelloCondizione: New. Establishes the criteria required to assess benefit-risk in general and reviews the current practice of benefit-risk assessment by drug regulatory authorities and the pharmaceutical industry. Outlines how the new MCDA model was developed and evaluated, and discusses the implications of its implementation into the practice of drug evaluation. Num Pages: 304 pages, Illustrations. BIC Classification: MBGR; MMG. Category: (P) Professional & Vocational. Dimension: 252 x 174 x 21. Weight in Grams: 670. . 2010. 1st Edition. Hardcover. . . . .
EUR 168,93
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. x + 294 Illus.
Condizione: New. Establishes the criteria required to assess benefit-risk in general and reviews the current practice of benefit-risk assessment by drug regulatory authorities and the pharmaceutical industry. Outlines how the new MCDA model was developed and evaluated, and discusses the implications of its implementation into the practice of drug evaluation. Num Pages: 304 pages, Illustrations. BIC Classification: MBGR; MMG. Category: (P) Professional & Vocational. Dimension: 252 x 174 x 21. Weight in Grams: 670. . 2010. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.